SUMMARY The in vivo recovery of factor VIII has been estimated on 84 occasions in 53 severely affected adolescent haemophiliacs. There was wide individual variation in recovery, which was not affected by differences in the administered dose. Recovery increased steadily with increasing surface area, and it was only over a surface area of 1-7 m2 that a recovery of 2% of factor VIII per unit per kg became the norm. It is suggested that the only safe assumption to make below that surface area is an in vivo recovery of 1[5 %.
The treatment of haemophilic haemarthroses with inadequate doses of factor VIII will predispose the joints to chronic synovitis, progressive arthropathy, and ultimately to crippling deformity.' There are, however, potentially harmful side effects associated with adequate and excessive exposure to factor VIIIcontaining materials,2 which also strain human and financial resources.3 Clearly, the use of the correct dose of factor VIII in varying situations is of great importance.
Recent studies have identified minimum dosage schedules for bleeds of varying severity in specific sites,4 and in joints with or without previous and/or present damage.5 If the minimum effective dose is to be used efficiently, it is crucial to be able to predict the rise in factor VIII activity that is likely to follow a given dose. Patients and methods
The subjects studied were 53 severely affected adolescent haemophiliacs (factor VIIIC < 1 %) resident at the Lord Mayor Treloar College. Blood samples were taken immediately before and between 20 and 30 minutes after infusions of factor VIII-containing material. Samples were immediately dispensed into plastic tubes containing 3 8 % sodium citrate (9 vols blood to 1 vol anticoagulant). The plasma was separated within two hours by centrifuging at 2000 g at 4°C and tested immediately.
Factor VIIIC was tested by a two stage method modified from that of Denson." During the year in which the study took place, approximately 700 factor VIII assays were undertaken in our laboratory, 10 % of which were done in duplicate. Average variation between operators was never more than 10%.
All weights and heights used were obtained within two months of the relevant estimation. Height was measured with patients standing without shoes and with their heels back in contact with an upright scale. Body surface area was calculated using a nomogram based on the formula of Du Bois and Du Bois.12
Recovery or response was expressed as the percentage rise of factor VIII per unit of factor VIII/kg infused. The dose of factor VIII infused was based on the unit-values given by the manufacturer. These were specifically checked on 19 occasions during the study. The preparations used were fractionated by Travenol laboratories, Armour, Immuno and the Lister Institute. On 16 occasions the assayed potency deviated by less than 10 % from the manufacturer's stated potency and on no occasion was a deviation of more than 20 % noted.
Haemoglobin concentrations were estimated using a Coulter model "S" counter. The relation between haemoglobin concentrations and recovery was calculated using Kendall's test of rank correlation.
Results

EFFECT OF INCREASING WEIGHT
A scattergram shows the dose response in small groups of boys with similar weights (Fig. 1 ). An increasing response is noted from the group weighing less than 40 kg (x = 1-67 ± 0-19) through the 40-44 kg group (x = 1-79 ± 0-24) to the 45-49 kg group (x = 2-16 ± 0 43). A similar response is seen from 55-59 kg (x = 1-87 ± 0-29) through 60-64 kg (xc = 2-07 ± 0-27) to the 65-69 kg group (x = 2-17 ± 0 35). There are significant differences between the under 40 kg and the 45-49 kg groups (p < 0-02) and between the 40-44 kg and the 45-49 kg groups (p < 0005). The difference between the 55-59 kg group and the 65-69 group is also significant (p < 0 05). 
EFFECT OF INCREASING DOSES OF FACTOR VIII
The scattergram shows the relation of the in vivo response to varying doses of factor VIII (Fig. 3) . There is no correlation between these two parameters (r = 0 38). The dose response of small groups of boys with similar surface areas are shown in Fig. 2 . The response begins to increase in the group with a surface area of 1 6 to 1-69 M2 (k = 1-90 ± 0-38) through the 1-7 to 1-79 M2 group (R = 2-04 ± 0-21) to the more than 1-8 m2 group (x = 2-23 ± 0-37).
The difference between the 1 6 to 1-69 m2 group and the greater than 1 8 m2 group is significant (p < 0-05). Effect of height and weight on the in vivo recovery of transfusedfactor VIII C surface area suggesst that variable potency is not likely to have a significant effect on our results.
Only one boy was anaemic and while two of his recoveries were below average, one was well into the high normal range. Overall we can see no correlation between haemoglobin concentrations and recovery, but not enough anaemic patients were available to test the hypothesis that haemoglobin concentrations might influence recovery. With modern surveillance fewer patients are likely to be anaemic and surface area therefore appears to be the most reliable indication of recovery. 
